Labetalol Hydrochloride Injection, Solution
Product Images NDC 0409-2267

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 0409-2267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Labetalol 01)

FDA Label Image

Structural Formula Labetalol HCl (Labetalol 02)

FDA Label Image

Hospira Logo (Labetalol 02a)

FDA Label Image

Principal Display Panel (100 mg/20 mL Vial Label)

FDA Label Image

Principal Display Panel (100 mg/20 mL Vial Carton)

Principal Display Panel (100 mg/20 mL Vial Carton)
This is a description of a medication called Labetalol Hydrochloride Injection, which is distributed by Hospira. This injection is for intravenous use only and contains 100 mg of labetalol hydrochloride in 20 ml of solution. Each milliliter has 5 mg of labetalol hydrochloride, 45 mg of anhydrous dextrose, and 0.10 mg of edetate disodium. The medication also contains preservatives such as 0.80 mg of methylparaben and 0.10 mg of propylparaben. The pH level is adjusted between 3.0 and 4.5 by sodium hydroxide and citric acid monohydrate. This medication should be stored in a controlled room temperature of 20 to 25 degrees Celsius and protected from freezing and light.*
FDA Label Image

Labetalol 05

Labetalol 05
This is a product label for Labetalol Hydrochloride Injection, USP. The injection is available in a 40 mL multiple-dose vial with a concentration of 200 mg/40 mL (5 mg/mL). It is intended for intravenous use and should be protected from freezing and light. The pH may be adjusted if necessary, and it contains labetalol hydrochloride, anhydrous dextrose, edetate disodium, propylparaben, and water for injection. This product is distributed by Hospira, Inc. in Lake Forest, IL. The rest of the text consists of lot numbers and a signature, and does not provide useful information.*
FDA Label Image

Labetalol 06

Labetalol 06
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.